Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$261M |
| 2 |
Alibaba
BABA
|
+$233M |
| 3 |
Truist Financial
TFC
|
+$191M |
| 4 |
Microsoft
MSFT
|
+$160M |
| 5 |
Amazon
AMZN
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$415M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$186M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$73.8M |
| 4 |
Oracle
ORCL
|
+$25.8M |
| 5 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
+$23.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 15.12% |
| 3 | Healthcare | 12.68% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Communication Services | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Agios Pharmaceuticals
AGIO
$1.89B
| $1.8M | ﹤0.01% |
37,621
+1,285
| +4% | +$48.6K |
|
1852
HealthStream
HSTM
$830M
| $1.79M | ﹤0.01% |
65,865
+3,638
| +6% | +$100K |
|
1853
Eldorado Gold
EGO
$9.49B
| $1.79M | ﹤0.01% |
222,751
-26,026
| -10% | -$202K |
|
1854
Amkor Technology
AMKR
$13.8B
| $1.79M | ﹤0.01% |
137,632
+31,152
| +29% | +$372K |
|
1855
Ultragenyx Pharmaceutical
RARE
$2.48B
| $1.78M | ﹤0.01% |
41,748
+6,692
| +19% | +$276K |
|
1856
Atlantic Union Bankshares
AUB
$6.14B
| $1.78M | ﹤0.01% |
47,458
+5,151
| +12% | +$194K |
|
|
MODV
1857
DELISTED
ModivCare
MODV
| $1.78M | ﹤0.01% |
30,091
+1,954
| +7% | +$119K |
|
1858
Customers Bancorp
CUBI
$2.8B
| $1.76M | ﹤0.01% |
74,022
+4,062
| +6% | +$93.3K |
|
|
AIMC
1859
DELISTED
Altra Industrial Motion Corp
AIMC
| $1.76M | ﹤0.01% |
48,524
| – | – |
|
1860
WillScot Mobile Mini Holdings
WSC
$4.83B
| $1.75M | ﹤0.01% |
94,631
+83,130
| +723% | +$1.4M |
|
1861
Zumiez
ZUMZ
$335M
| $1.74M | ﹤0.01% |
50,460
+3,021
| +6% | +$95.5K |
|
1862
Harmonic Inc
HLIT
$1.32B
| $1.74M | ﹤0.01% |
223,428
+14,032
| +7% | +$105K |
|
1863
RE/MAX Holdings
RMAX
$205M
| $1.74M | ﹤0.01% |
45,279
+2,765
| +7% | +$99.3K |
|
1864
Antero Resources
AR
$10.7B
| $1.74M | ﹤0.01% |
610,311
+239,268
| +64% | +$611K |
|
|
USCR
1865
DELISTED
U S Concrete, Inc.
USCR
| $1.74M | ﹤0.01% |
41,720
+3,196
| +8% | +$146K |
|
|
EGRX
1866
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.73M | ﹤0.01% |
28,790
+1,755
| +6% | +$105K |
|
1867
Conduent
CNDT
$270M
| $1.73M | ﹤0.01% |
278,385
+34,425
| +14% | +$215K |
|
1868
iShares Core S&P 500 ETF
IVV
$901B
| $1.73M | ﹤0.01% |
5,340
+140
| +3% | +$43.3K |
|
1869
Myers Industries
MYE
$1.34B
| $1.73M | ﹤0.01% |
103,409
+6,629
| +7% | +$110K |
|
1870
National Beverage
FIZZ
$3.01B
| $1.72M | ﹤0.01% |
67,512
+3,670
| +6% | +$88.2K |
|
|
BHVN
1871
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.71M | ﹤0.01% |
31,437
+922
| +3% | +$45.7K |
|
|
HSKA
1872
DELISTED
Heska Corp
HSKA
| $1.71M | ﹤0.01% |
17,820
+1,533
| +9% | +$133K |
|
|
CHS
1873
DELISTED
Chicos FAS, Inc.
CHS
| $1.71M | ﹤0.01% |
447,510
+58,758
| +15% | +$226K |
|
|
AYR
1874
DELISTED
Aircastle Ltd
AYR
| $1.71M | ﹤0.01% |
53,288
+20,483
| +62% | +$592K |
|
1875
Box
BOX
$4.44B
| $1.7M | ﹤0.01% |
101,405
+6,672
| +7% | +$112K |
|
Similar funds
Legal & General Group's Q4 2019 Portfolio in Review
As of Q4 2019, Legal & General Group held 3,425 positions worth $210B, up 11% from $190B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3.9%. Legal & General Group opened 77 new positions and exited 57, leaving the 3,425-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Legal & General Group's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 425,000 shares worth $19.1M.
- Legal & General Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $261M increase.
- Legal & General Group's biggest Q4 2019 reduction was Oracle, cutting an estimated $25.8M.
- Legal & General Group fully exited Celgene Corp in Q4 2019, selling an estimated $415M.
- Legal & General Group's ten largest holdings make up 18% of its $210B portfolio in Q4 2019.
- Legal & General Group opened 77 new positions and closed 57 in Q4 2019.
- Legal & General Group's portfolio value rose 11% quarter-over-quarter to $210B.
Based on Legal & General Group's 13F filing for Q4 2019, filed 13 Feb 2020.